Related Experiment Videos
Modulation of action potential duration on myocyte hypertrophic pathways
Djamel Lebeche1, Roger Kaprielian, Roger Hajjar
1Cardiovascular Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, 02129, USA. dlebeche@partners.org
Journal of Molecular and Cellular Cardiology
|April 8, 2006
Summary
Enhancing the transient outward potassium current (I(to)) by overexpressing Kv4.3 in cardiomyocytes inhibits angiotensin II-induced hypertrophy. This suggests modulating action potential duration is key in cardiac hypertrophy development.
Area of Science:
- Cardiology
- Molecular Biology
- Electrophysiology
Background:
- Cardiac hypertrophy and failure are linked to prolonged action potential duration (APD).
- Reduced hyperpolarizing current from calcium-independent transient outward K+ channels (I(to)) contributes to APD prolongation.
- Angiotensin II (AngII) is a key mediator of cardiac hypertrophy.
Purpose of the Study:
- To investigate the impact of manipulating I(to) and sodium/calcium exchanger (NCX) currents on cardiomyocyte hypertrophy induced by AngII.
- To determine if distinct intracellular calcium patterns influence MAPkinase activation and cellular hypertrophy.
- To explore the role of action potential duration in AngII-mediated cardiac hypertrophy.
Main Methods:
- Cultured neonatal rat ventricular myocytes (NRVMs) were infected with adenoviruses for Kv4.3, Kv4.3 antisense, or NCX.
- Hypertrophy was induced by incubating NRVMs with AngII.
- Measurements included I(to) density, APD, Ca(2+) influx, protein expression (ANF, beta-MHC), and MAPkinase/calcineurin activation.
Main Results:
- Overexpression of Kv4.3 increased I(to), shortened APD, reduced Ca(2+) influx, and inhibited AngII-induced hypertrophy markers.
- Kv4.3 overexpression blocked ERK MAP kinases and calcineurin expression.
- These effects were reversed by Kv4.3 antisense and NCX gene transfer.
Conclusions:
- Enhanced I(to) function via Kv4.3 overexpression abrogates AngII-mediated hypertrophy in NRVMs.
- Modulating action potential duration is a significant factor in cardiac hypertrophy development.
- Targeting I(to) channels offers a potential therapeutic strategy for cardiac hypertrophy.